The Rogosin Institute Comprehensive Lipid Control Center is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The Rogosin Institute Comprehensive Lipid Control Center has participated in 1 clinical trials.
Therapeutic areas: Heterozygous Familial Hypercholesterolemia, Coronary Artery Disease.
Sponsors: Kastle Therapeutics, LLC.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Rogosin Institute Comprehensive Lipid Control Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Rogosin Institute Comprehensive Lipid Control Center has 1 clinical trials on record. Their work covers Heterozygous Familial Hypercholesterolemia, Coronary Artery Disease.
The Rogosin Institute Comprehensive Lipid Control Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.